Last quarter (Q4 2023), Acorda Therapeutics's total revenue was $37.98M, an increase of 20.70% from the same quarter last year. In Q4, Acorda Therapeutics's net income was $-217.76M. See Acorda Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 117.63M	$ 117.63M	$ 118.57M	$ 129.07M	$ 152.97M	$ 192.41M
Cost of Revenue	$ 15.28M	$ 15.28M	$ 30.33M	$ -40.79M	$ 33.51M	$ 34.85M
Gross Profit	$ 102.35M	$ 102.35M	$ 88.23M	$ 88.28M	$ 119.45M	$ 157.56M
Operating Expense	$ 125.61M	$ 125.61M	$ 142.82M	$ 165.58M	$ 206.35M	$ 278.56M
Operating Income	$ -266.87M	$ -264.95M	$ -35.34M	$ -77.30M	$ -86.90M	$ -121.01M
Net Non Operating Interest Income Expense	$ -31.00M	$ -31.00M	$ -28.29M	$ -30.03M	$ -29.76M	$ -17.70M
Other Income Expense	$ 241.47M	$ 241.47M	$ -35.09M	$ 1.75M	$ 8.99M	$ -135.54M
Pretax Income	$ -296.02M	$ -296.02M	$ -35.25M	$ -109.07M	$ -107.67M	$ -274.25M
Tax Provision	$ -43.17M	$ -43.17M	$ 30.67M	$ -5.12M	$ -8.07M	$ -1.28M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -252.85M	$ -252.85M	$ -65.92M	$ -103.95M	$ -99.59M	$ -272.97M
Basic EPS	$ -187.26	$ -203.57	$ -3.34	$ -9.79	$ -12.32	$ -34.50
Diluted EPS	$ -187.26	$ -203.57	$ -3.34	$ -9.79	$ -12.32	$ -34.50
Basic Average Shares	$ 28.09M	$ 1.24M	$ 19.71M	$ 10.62M	$ 8.08M	$ 7.92M
Diluted Average Shares	$ 28.09M	$ 1.24M	$ 19.71M	$ 10.62M	$ 8.08M	$ 7.92M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	$ -54.12	$ -10.32
Reported Normalized Diluted E P S	-	-	-	-	$ -54.12	$ -10.32
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 140.90M	$ 140.90M	$ 112.49M	$ 124.80M	$ 239.86M	$ 313.41M
Net Income From Continuing And Discontinued Operation	$ -252.85M	$ -252.85M	$ -65.92M	$ -103.95M	$ -99.59M	$ -272.97M
Normalized Income	$ -75.58M	$ -97.57M	-	-	$ -107.75M	$ -138.09M
Interest Expense	-	-	-	-	$ 30.57M	$ 21.87M
EBIT	$ -264.49M	$ -264.49M	$ -12.20M	$ -79.04M	$ -77.09M	$ -252.38M
EBITDA	$ -213.71M	$ -213.71M	$ 37.53M	$ -28.81M	$ -35.80M	$ -217.80M

Currency in USD

Acorda Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing